[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Intermountain Health Care, Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":259},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,10,0,[8,39,68,91,122,144,167,191,210,237],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":38},"100243643","intermountain-inspire-registry-100243643",false,"NCT02450006","Intermountain INSPIRE Registry","INtermountain Healthcare Biological Samples Collection Project and Investigational REgistry for the On-going Study of Disease Origin, Progression and Treatment (Intermountain INSPIRE Registry)","Inclusion Criteria:\n\n* Males or females of any age, any ethnicity, diagnosed with any healthcare-related conditions, presenting to an Intermountain Healthcare-affiliated facility or males or females of any age, any ethnicity, with or without any healthcare-related conditions, including disease-free subjects, from a general population that may include unaffected family members\n* Patient or patient's representative has the ability to understand and sign a written informed consent form, which must be obtained prior to initiation of any study procedures, using a form that is approved by the applicable IRB.\n\nExclusion Criteria:\n\n* Inability or refusal of the patient and\u002For the patient's legally-acceptable representative to provide informed consent for any reason.\n* Other conditions that in the opinion of the Principal Investigator or Co-Investigator(s) may increase risk to the subject and\u002For compromise the quality of the registry project.",true,"ALL",{"count":19,"type":20},50000,"ESTIMATED","50 Years","OBSERVATIONAL","To collect biological samples, clinical information and laboratory data from patients diagnosed with any healthcare-related conditions who are seen at facilities affiliated with Intermountain Healthcare, including patients and their family members, and to collect the same information and samples from a general population including disease-free subjects.",[25],"Condition","RECRUITING","2026-04-09",{"date":29,"type":30},"2026-04-14","ACTUAL",{"date":32,"type":4},"2015-04",{"date":34,"type":20},"2050-04",{"name":36,"class":37},"Intermountain Health Care, Inc.","OTHER",1,{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":11,"sex":17,"minAge":47,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":50,"phases":51,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":58,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},"100621920","phase-4-combination-antibiotic-therapy-for-staphylococcus-aureus-bacteremia-100621920","NCT07376889","Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia","COMBAT-SAB: Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia","COMBAT-SAB","Inclusion Criteria:\n\n* Age ≥18 years\n* Alive and admitted to an Intermountain Health (IH) hospital acute care unit at enrollment\n* Initial positive blood culture with either methicillin-resistant Staphylococcus aureus (MRSA) or methicillin-susceptible Staphylococcus aureus (MSSA), collected:\n\n  1. on or during the index admission to an IH hospital, or\n  2. in an ambulatory setting (laboratory, clinic or emergency department) within 48 hours of the index admission, or\n  3. at a non-IH network hospital within 24 hours of subsequent transfer to an IH hospital\n\n     Exclusion Criteria:\n* Patient requests that patient health data not be included in the analysis","18 Years",{"count":49,"type":20},2096,"INTERVENTIONAL",[52],"PHASE4","The purpose of this study is to see if, in selected patients with a serious bacterial infection of the bloodstream, treating the bacterial infection with a combination of antibiotics is more effective than treating the infection with a single antibiotic. Participants must have blood cultures which are positive for a certain type of bacteria.",[55],"Staphylococcus Aureus Bacteremia",[57],"Combination antibiotic therapy","NOT_YET_RECRUITING","2026-01-26",{"date":61,"type":30},"2026-01-29",{"date":63,"type":20},"2026-02-01",{"date":65,"type":20},"2029-01",{"name":36,"class":37},13,{"id":69,"slug":70,"hasResults":11,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":76,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":78,"conditions":79,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":38},"100619720","pivo-use-for-blood-cultures-in-the-emergency-department-100619720","NCT07348289","PIVO Use for Blood Cultures in the Emergency Department","PIVO-ED: Protocol for Intermountain Venous Access Optimization for Blood Cultures in the Emergency Department","PIVO-ED","Inclusion Criteria: Patients in whom blood cultures are obtained in the emergency department.\n\n\\-\n\nExclusion Criteria: none\n\n\\-",{"count":77,"type":20},10000,"The investigators will implement a protocol for use of the PIVO device for blood culture collection in the emergency department. This protocol utilizes the device in various scenarios to reduce needlesticks while allowing for accurate and appropriate assessment of potential pathogens in the bloodstream. The study team will train staff on use of the device then monitor utilization and contamination rates among emergency department patients.",[80,81,82],"Sepsis","Device Performance","Emergency Medicine","2026-01-09",{"date":85,"type":30},"2026-01-16",{"date":87,"type":30},"2025-10-01",{"date":89,"type":20},"2027-07-31",{"name":36,"class":37},{"id":92,"slug":93,"hasResults":11,"nctId":94,"briefTitle":95,"officialTitle":96,"acronym":97,"eligibilityCriteria":98,"healthyVolunteers":11,"sex":17,"minAge":99,"maxAge":100,"enrollmentInfo":101,"targetDuration":4,"studyType":50,"phases":103,"briefSummary":105,"conditions":106,"keywords":110,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":121},"100518710","interventions-to-de-implement-unnecessary-antibiotic-prescribing-for-children-with-ear-infections-100518710","NCT06034080","Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections","DISAPEAR Trial: Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections","DISAPEAR","Inclusion Criteria:\n\nA. Implementation of Interventions 1. Clinic at a participating organization 2. Provides care to children with AOM 3. Administrative or local approval for participation\n\nB. Secondary Electronic Health Record Data\n\n1. Aged 6 months-17-years-old (inclusive)\n2. Diagnosis of AOM by ICD10 code\n\nC. Video recordings or direct observation of the use of a shared decision aid\n\nParent participation:\n\n1. Child aged 6 months-17 years (inclusive)\n2. Diagnosed with AOM by clinician\n3. Parent or legal guardian is present and is \\>=18 years or older\n\nClinician Participation:\n\n1. Licensed clinician and not a medical trainee\n2. Age 18 \\>= years or older\n\nD. Pre-implementation interviews of clinicians and administrators\n\n1. Licensed clinician (physician or advanced practice clinician) that cares for children with AOM at a participating organization or an administrator\u002Fmanager at a participating organization.\n2. Aged \\>=18 years-no maximum\n\nE. Pre-implementation focus groups of parents\n\n1. Parent or legal guardian of a child aged 6 months-17 years (inclusive) that has had AOM diagnosed at a participating organization.\n2. 18 years of age or older and able\u002Fwilling to consent\n\nF. Parents enrolled for surveys\n\n1\\. Parent or legal guardian of a child aged 6 months-17 years (inclusive) that has had AOM diagnosed at a participating organization. 2. Willing to participate and able to complete electronic surveys at enrollment and 10 days after enrollment. 3. Working phone 4. Age \\>=18 years of age\n\nG. Post-intervention focus groups of parents\n\n1. Parent or legal guardian of a child aged 6 months-17 years (inclusive) that has had AOM diagnosed at a participating organization.\n2. 18 years of age or older and able\u002Fwilling to consent\n\nH. Post-intervention surveys of clinicians and administrators\n\n1. Licensed clinician (physician or advanced practice clinician) that cares for children with AOM at a participating organization or an administrator\u002Fmanager at a participating organization.\n2. Aged \\>=18 years-no maximum\n\nExclusion Criteria:\n\nA. Implementation of Interventions\n\n1\\. Clinics that exclusively provide telehealth\n\nB. Secondary Electronic Health Record Data\n\n1\\. None\n\nC. Video recordings or direct observation of the use of a shared decision aid\n\nParent participation:\n\n1\\. None\n\nClinician Participation:\n\n1\\. None\n\nD. Pre-implementation interviews of clinicians and administrators 1. Medical trainee (student, resident, fellow, etc.)\n\nE. Pre-implementation focus groups of parents\n\n1\\. None\n\nF. Parents enrolled for surveys 1. Complicated or recurrent AOM as determined by the study team\n\nG. Post-intervention focus groups of parents 1. None\n\nH. Post-intervention surveys of clinicians and administrators\n\n1\\. Medical trainee (student, resident, fellow, etc.)","6 Months","17 Years",{"count":102,"type":20},1566,[104],"NA","This study aims to improve care and reduce unnecessary antibiotic prescribing for children with ear infections. The study will compare the effectiveness of a \"gold standard\" to a hybrid intervention combined with this gold standard, in order to identify steps to increase parent satisfaction for child ear infection care. The \"gold standard\" approach is a Health System Level Intervention. On its own, it involves clinician education, tools in electronic medical records, and audit and feedback reports for clinician prescribing habits. The hybrid intervention includes the elements of the health systems level intervention in addition to a Shared Decision-Making component, which allows for both an increase in the role parents play in their child's care, as well as clinician education for how to use this method. The goals of this work are to increase parent satisfaction, reduce antibiotics taken for childhood ear infections, align medical care with the current national guidelines, and evaluate differences in the two intervention groups. Both groups will be evaluated for implementation outcomes to improve dissemination and scalability for future use of these models in antibiotic prescribing for children with ear infections.\n\nThis study will recruit a diverse group of patients and clinicians to complete surveys, parents to participate in focus groups, and clinicians and administrators to be interviewed in order to meet study aims and receive sufficient feedback on the interventions performed. There are two hypotheses for this research: 1. The Hybrid Intervention will have higher parent satisfaction and reduced antibiotic use compared to the Health-System Level Intervention and 2. The Hybrid Intervention will be more challenging to implement than the Health-System Level Intervention, but will be preferred by parents, clinicians, and administrators.",[107,108,109],"Acute Otitis Media","Ear Infection","Pediatric Infectious Disease",[111,112],"Shared Decision-Making","Health-System Level Intervention","2025-08-26",{"date":115,"type":30},"2025-09-03",{"date":117,"type":30},"2025-02-03",{"date":119,"type":20},"2029-06",{"name":36,"class":37},3,{"id":123,"slug":124,"hasResults":11,"nctId":125,"briefTitle":126,"officialTitle":127,"acronym":128,"eligibilityCriteria":129,"healthyVolunteers":11,"sex":17,"minAge":47,"maxAge":4,"enrollmentInfo":130,"targetDuration":4,"studyType":50,"phases":132,"briefSummary":133,"conditions":134,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":136,"lastUpdatePostDateStruct":137,"startDateStruct":139,"completionDateStruct":141,"leadSponsor":143,"locationsCount":38},"100559978","a-pragmatic-initiative-for-ldl-c-management-by-a-clinical-pharmacist-led-team-among-atherosclerotic-cardiovascular-disease-patients-100559978","NCT06571162","A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients","A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients (The INCLUDE Trial)","INCLUDE","Inclusion Criteria:\n\n1. Male or female \\>18 years of age\n2. Receive follow-up care with Intermountain Health\n3. Value-based patient (as defined in the EDW)\n4. Documentation of an ASCVD diagnosis, by 1 of the following:\n\n   * Coronary artery disease (Primary inpatient CAD diagnosis during index encounter; Primary inpatient MI diagnosis during index encounter; PCI during index encounter; or CABG during index encounter\n   * Cerebrovascular accident (Primary inpatient ischemic stroke diagnosis during index encounter; Carotid endarterectomy during index encounter; or Carotid stent during index encounter)\n   * Peripheral arterial disease (Bypass or percutaneous intervention during index encounter)\n\nExclusion Criteria:\n\n1. Patient age \\\u003C18 years.\n2. Receipt of or expected receipt of palliative care, expected discharge to hospice, or long-term care facility (i.e., skilled nursing facility).\n3. Pregnant or lactating women",{"count":131,"type":20},400,[104],"Patients who had an ASCVD event at an Intermountain hospital will be screened for eligibility to be randomized. Subjects who meet eligibility criteria will be randomized 1:1 to receive targeted care of their LDL-C through a pharmacist-driven management program or not. Patients may opt-out of receiving LDL-C management by the pharmacy team at any time. The purpose of this program is to increase the proportion of patients who achieve guideline-based recommendations of LDL-C levels of \\\u003C70 mg\u002FdL by increasing statin and\u002For LLT adherence and LDL-C testing. Data collection as part of the study will continue until the last person randomized has had 1-year of follow-up.",[135],"Atherosclerotic Cardiovascular Disease","2025-05-01",{"date":138,"type":30},"2025-05-06",{"date":140,"type":30},"2025-01-30",{"date":142,"type":20},"2028-09",{"name":36,"class":37},{"id":145,"slug":146,"hasResults":11,"nctId":147,"briefTitle":148,"officialTitle":149,"acronym":4,"eligibilityCriteria":150,"healthyVolunteers":16,"sex":17,"minAge":151,"maxAge":4,"enrollmentInfo":152,"targetDuration":4,"studyType":50,"phases":154,"briefSummary":155,"conditions":156,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":158,"lastUpdatePostDateStruct":159,"startDateStruct":161,"completionDateStruct":163,"leadSponsor":165,"locationsCount":166},"100409081","adaptation-and-pilot-implementation-of-epna-clinical-decision-support-for-utah-urgent-care-clinics-100409081","NCT04606849","Adaptation and Pilot Implementation of ePNa Clinical Decision Support for Utah Urgent Care Clinics","Adaptation and Pilot Implementation of a Validated, Electronic Real-Time Clinical Decision Support Tool for Care of Pneumonia Patients in 10 Utah Urgent Care Centers","Inclusion Criteria:\n\n* All patients ≥ 12 years of age with pneumonia: defined by the J-18.X pneumonia code or acute respiratory failure or sepsis with secondary pneumonia codes\n\nSurvey All physicians and advanced practice clinicians who are employed and actively seeing patients in the 4 Utah Valley Instacares\n\nExclusion Criteria:\n\n* Patients without radiographic confirmation of pneumonia\n* Subsequent episodes of pneumonia within 12 months (so as not to over-represent patients with recurrent pneumonia caused by recurrent aspiration or structural lung disease).\n\nSurvey No providers will be excluded from the survey invitation","12 Years",{"count":153,"type":20},4000,[104],"We plan to adapt an innovative, validated emergency department (ED) CDS tool based on consensus guidelines for pneumonia care (ePNa) to function in urgent care clinics (Instacares at Intermountain) and combine it seamlessly with Stanford's CheXED artificial intelligence model using an interoperable platform currently under development by Care Transformation Information Services at Intermountain. We will then deploy it to one of two groups of Instacares (randomly selected) using the CFIR framework for Implementation Science best practice.",[157],"Pneumonia","2024-08-22",{"date":160,"type":30},"2024-08-26",{"date":162,"type":30},"2020-11-12",{"date":164,"type":20},"2024-09-30",{"name":36,"class":37},12,{"id":168,"slug":169,"hasResults":11,"nctId":170,"briefTitle":171,"officialTitle":172,"acronym":173,"eligibilityCriteria":174,"healthyVolunteers":11,"sex":17,"minAge":175,"maxAge":176,"enrollmentInfo":177,"targetDuration":4,"studyType":50,"phases":179,"briefSummary":180,"conditions":181,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":183,"lastUpdatePostDateStruct":184,"startDateStruct":186,"completionDateStruct":188,"leadSponsor":190,"locationsCount":38},"100551628","live-and-interactive-fitness-training-program-vivo-knee-oa-100551628","NCT06462560","Live and Interactive Fitness Training Program (Vivo Knee OA)","Improving Physical Function and Quality of Life in Adults With Knee Osteoarthritis Utilizing an Online Live and Interactive Fitness Training Program (Vivo Knee OA)","LIFT-OA","Inclusion Criteria:\n\n* 55-85 years of age\n* Diagnosis of Osteoarthritis within the prior 6 months\n* Symptomatic OA defined as self-report:\n\n  * Pain in the knee(s) on most days of the month\n  * Difficulty with at least one of the following because of knee pain:\n\n    * walking ¼ of a mile\n    * climbing stairs\n    * getting in and out of a car, bath, or bed\n    * rising from a chair\n    * or performing shopping, cleaning, or self-care activities\n* Radiographic KL grade II-III (using Kellgren and Lawrence criteria) of one or both knees\n* Physically able to participate in strength training - able to do one chair stand unassisted in order to test change in 30-second chair stand\n* Ambulatory and community-dwelling\n* Sedentary or insufficiently active as measured by the PAVS\n* Access to Wi-Fi in defined exercise space\n* BMI of 20-34.9 kg\u002Fm2\n* Document medication specific to OA and knee pain\n* Willing and able to provide consent\n\nExclusion Criteria:\n\n* Neurological conditions causing functional impairments (Parkinson's disease, MS, ALS)\n* Diagnosis of dementia\n* Inability to complete ≥1 ADLs without assistance.\n* Knee surgery in the past 6 months\n* Severe osteoporosis T-score \\\u003C -3.5\n* No concurrent enrollment in physical therapy for knee pain\n* No concurrent enrollment in the Intermountain Arthrofit program\n* Under the age of 55 or ≥85\n* Asymptomatic OA\n* Not having knee pain or having significant knee pain (WOMAC Pain score of ≤3 or ≥18)\n* KL Grade 1 or 4\n* BMI above 34.9 kg\u002Fm2 or ≤20 kg\u002Fm2\n* Participation in formal strength training more than 30 minutes a week in the past 6 months.\n* PAVS - Participating in 150 minutes per week of moderate intensity physical activity or 75 minutes of vigorous intensity activity, or an equivalent combination of moderate and vigorous intensity physical activity.\n* Co-morbid disease that would threaten safety or impair ability to participate in a live and interactive strength training program\n* Symptomatic or severe coronary artery disease; peripheral vascular disease\n* Untreated hypertension\n* Active cancer other than skin cancer","55 Years","85 Years",{"count":178,"type":20},334,[104],"Potential participants will be screened at clinic. Patients who meet eligibility criteria will be considered for study. After written informed consent is obtained, participants will complete baseline testing and participants who meet eligibility criteria will be randomized 1:1 to 2 treatment arms: Vivo Arm: Vivo twice a week for 6 months and Usual Care Arm: meet with ATC and given Medbridge home exercise program for 6 months. All participants will be followed for 12 months, and will be assessed at 3-,6-, and 12-months. All participants will complete functional assessments, OA patient reported outcomes measures, quality of life, exercise self-efficacy, and fall risk questionnaires, and health care utilization report at each testing visit. A subset of Vivo participants will be asked satisfaction questions at the 3 and 6 month time points.",[182],"Knee Osteoarthritis","2024-06-12",{"date":185,"type":30},"2024-06-17",{"date":187,"type":30},"2024-04-28",{"date":189,"type":20},"2026-04",{"name":36,"class":37},{"id":192,"slug":193,"hasResults":11,"nctId":194,"briefTitle":195,"officialTitle":196,"acronym":4,"eligibilityCriteria":197,"healthyVolunteers":11,"sex":17,"minAge":47,"maxAge":4,"enrollmentInfo":198,"targetDuration":99,"studyType":22,"phases":4,"briefSummary":199,"conditions":200,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":202,"lastUpdatePostDateStruct":203,"startDateStruct":205,"completionDateStruct":207,"leadSponsor":209,"locationsCount":38},"100524170","biological-sex-and-cteph-related-rv-dysfunction-and-recovery-biosphere-100524170","NCT06105242","Biological Sex and CTEPH-related RV Dysfunction and Recovery (BIOSPHeRe)","Biological Sex and Sex Hormones Moderate Right Ventricular (RV) Dysfunction and Recovery in Chronic Thromboembolic Pulmonary Hypertension","Inclusion criteria\n\n* Adult (≥18 years old) patients diagnosed with CTEPH per current guideline standard42\n* Subject must have a baseline TTE (within 3 months of diagnosis) with adequate images for RVGLS analysis\n* Subject must have a right heart catheterization (RHC) at the time of diagnosis\n* To be included in the Aim 2 analysis, patients must undergo PTE surgery and have a TTE performed 3-9 months after surgery with adequate images for RVGLS strain analysis\n\nExclusion criteria\n\n* Unclear or mixed PH diagnosis as designated by an expert clinician at Intermountain PH center\n* Any subjects \\\u003C18 years of age\n* Patients diagnosed during pregnancy\n* Patients without a TTE and RHC at time of diagnosis",{"count":5,"type":20},"1. To identify biological sex differences in baseline RV function in CTEPH\n2. To identify biological sex differences in recovery of RV function after PTE surgery in CTEPH\n3. To determine if sex hormone levels relate to RV function at CTEPH diagnosis and during recovery after PTE.",[201],"CTEPH","2023-10-23",{"date":204,"type":30},"2023-10-27",{"date":206,"type":30},"2022-05-30",{"date":208,"type":20},"2026-12-31",{"name":36,"class":37},{"id":211,"slug":212,"hasResults":11,"nctId":213,"briefTitle":214,"officialTitle":215,"acronym":216,"eligibilityCriteria":217,"healthyVolunteers":11,"sex":17,"minAge":218,"maxAge":4,"enrollmentInfo":219,"targetDuration":4,"studyType":50,"phases":221,"briefSummary":222,"conditions":223,"keywords":225,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":228,"lastUpdatePostDateStruct":229,"startDateStruct":231,"completionDateStruct":233,"leadSponsor":235,"locationsCount":236},"100450123","telehealth-enabled-real-time-audit-and-feedback-for-clinician-adherence-teach-100450123","NCT05141396","Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)","Implementation of Coordinated Spontaneous Awakening and Breathing Trials Using Telehealth-Enabled, Real-Time Audit and Feedback for Clinician Adherence: A Type II Hybrid Effectiveness-Implementation","TEACH","Inclusion criteria:\n\n* Patient age \\>=16 years admitted to study hospital ICU\n* Intubated and mechanically ventilated\n\nExclusion criteria:\n\n* Patient with pre-existing brain death admitted to study hospital for organ donation\n* Died within 24 hours of intubation","16 Years",{"count":220,"type":20},13400,[104],"The purpose of this trial is to evaluate if augmenting a usual audit and feedback implementation approach with telehealth-enabled support improves coordinated spontaneous awakening\u002Fbreathing trials and patient outcomes for mechanically ventilated patients.",[224],"Respiration, Artificial",[226,227],"Invasive Mechanical Ventilation","Coordinated Spontaneous Awakening and Breathing Trials","2023-06-29",{"date":230,"type":30},"2023-07-03",{"date":232,"type":30},"2022-09-01",{"date":234,"type":20},"2026-10-15",{"name":36,"class":37},11,{"id":238,"slug":239,"hasResults":11,"nctId":240,"briefTitle":241,"officialTitle":242,"acronym":243,"eligibilityCriteria":244,"healthyVolunteers":16,"sex":17,"minAge":47,"maxAge":4,"enrollmentInfo":245,"targetDuration":247,"studyType":22,"phases":4,"briefSummary":248,"conditions":249,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":251,"lastUpdatePostDateStruct":252,"startDateStruct":254,"completionDateStruct":256,"leadSponsor":258,"locationsCount":38},"100376915","precision-genomics-medicine-biobank-100376915","NCT04187729","Precision Genomics Medicine Biobank","Intermountain Healthcare's - PRECISion MEdicine Biobank","PRECISE","Group #1 inclusion criteria\n\n* Male and female adults (≥ 18 years of age)\n* Diagnosed with any healthcare-related condition(s)\n* Subject presenting to an Intermountain Healthcare facility\n\nGroup #2 inclusion criteria\n\n* Male and female adults (≥ 18 years of age)\n* Reportedly healthy (i.e., non-diseased)\n* Subject presenting to an Intermountain Healthcare facility\n\nGroups #1 and 2 exclusion criteria\n\n* Inability or refusal of the patient and\u002For the patient's legally-acceptable representative to provide informed consent for any reason\n* Other conditions that the Principal Investigators or Co-Investigators believe may increase the risk to the subject and\u002For compromise the scientific integrity of the registry",{"count":246,"type":20},100000,"25 Years","The immediate goal of this study is to collect biological samples (i.e., tissue and\u002For fluid), clinical information, and laboratory data from disease and non-disease subjects seen at Intermountain Healthcare affiliated facilities. The long-term goal is to annotate tissue and\u002For fluid biomarker data to clinical information and laboratory data for the purpose of improving health care delivery and prognostic potential.",[250],"Any Disease Condition and Reportedly-healthy Subjects","2022-04-18",{"date":253,"type":30},"2022-04-20",{"date":255,"type":30},"2017-10-24",{"date":257,"type":20},"2077-10-24",{"name":36,"class":37},""]